Maternal TSH and FT4 changes during pregnancy as risk factors for preeclampsia in euthyroid women - Scorecard - MDSpire

Maternal TSH and FT4 changes during pregnancy as risk factors for preeclampsia in euthyroid women

  • By

  • Jianxia Lin

  • Yili Zhang

  • Yu Meng

  • Yan Su

  • Mengfan Song

  • May 26, 2026

  • 0 min

Share

Clinical Scorecard: Changes in Maternal TSH and FT4 Levels Throughout Pregnancy as Potential Risk Indicators for Preeclampsia in Euthyroid Women

At a Glance

CategoryDetail
Condition
Key MechanismsChanges in TSH and FT4 levels during pregnancy as observed in the study.
Target Population
Care Setting

Key Highlights

  • TSH changes show a J-shaped nonlinear association with preeclampsia risk.
  • FT4 changes are linearly and negatively associated with preeclampsia risk.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • Significant increases in TSH combined with decreases in FT4 are associated with higher risk of preeclampsia.

        Patient & Prescribing Data

        Pregnant women with normal thyroid function

        Monitoring thyroid hormone levels may help identify risk for preeclampsia.

        Clinical Best Practices

        • Utilize trimester-specific reference ranges for TSH and FT4 in pregnant women.
        • Conduct systematic prenatal examinations to monitor thyroid function.

        Related Resources & Content

        Original Source(s)

        Related Content